We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+30.6%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$43.1B
AUM Growth
+$3.9B
Cap. Flow
+$196M
Cap. Flow %
0.46%
Top 10 Hldgs %
17.24%
Holding
3,508
New
269
Increased
1,735
Reduced
1,181
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 9.57%
2 Healthcare 9.13%
3 Financials 8.63%
4 Industrials 6.92%
5 Communication Services 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEB icon
2701
Seaboard Corp
SEB
$4.06B
$292K ﹤0.01%
70
EVEP
2702
DELISTED
EV Energy Partners, L.P.
EVEP
$292K ﹤0.01%
197,224
-14,495
-7% -$26K
NPKI
2703
NPK International
NPKI
$1.14B
$288K ﹤0.01%
35,533
-474
-1% -$3.64K
IBDJ
2704
DELISTED
iShares iBonds Dec 2017 Term Corporate ETF
IBDJ
$288K ﹤0.01%
+11,605
New +$288K
OI icon
2705
O-I Glass
OI
$1.08B
$287K ﹤0.01%
14,073
-343,860
-96% -$6.74M
JPMV
2706
DELISTED
iShares Edge MSCI Min Vol Japan ETF
JPMV
$287K ﹤0.01%
4,800
+856
+22% +$50.5K
HEQ
2707
John Hancock Hedged Equity & Income Fund
HEQ
$140M
$286K ﹤0.01%
16,946
-1,210
-7% -$19.9K
NEU icon
2708
NewMarket
NEU
$8.18B
$285K ﹤0.01%
629
+129
+26% +$56.5K
CLVS
2709
DELISTED
Clovis Oncology, Inc.
CLVS
$285K ﹤0.01%
4,479
-2,544
-36% -$155K
IGD
2710
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$517M
$282K ﹤0.01%
38,371
-5,494
-13% -$39.1K
WW
2711
DELISTED
WW International
WW
$282K ﹤0.01%
18,135
+5,149
+40% +$70.8K
BPT
2712
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$281K ﹤0.01%
+14,003
New +$349K
USNA icon
2713
Usana Health Sciences
USNA
$286M
$281K ﹤0.01%
+4,885
New +$292K
CUZ icon
2714
Cousins Properties
CUZ
$4.88B
$280K ﹤0.01%
8,478
-2,160
-20% -$72.5K
JRS icon
2715
Nuveen Real Estate Income Fund
JRS
$246M
$280K ﹤0.01%
25,233
+729
+3% +$8.1K
MYJ
2716
DELISTED
Blackrock Muni Yield New Jersey Fund, Inc.
MYJ
$279K ﹤0.01%
18,219
+120
+0.7% +$1.85K
GOLD
2717
DELISTED
Randgold Resources Ltd
GOLD
$279K ﹤0.01%
3,192
-19,190
-86% -$1.67M
MCY icon
2718
Mercury Insurance
MCY
$6.07B
$278K ﹤0.01%
4,558
-25
-0.5% -$1.49K
CXP
2719
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
$278K ﹤0.01%
+12,500
New +$279K
AIR icon
2720
AAR Corp
AIR
$5.76B
$277K ﹤0.01%
8,241
-460
-5% -$15.3K
ARCB icon
2721
ArcBest
ARCB
$3.08B
$277K ﹤0.01%
10,640
-4,937
-32% -$145K
AVNS
2722
DELISTED
Avanos Medical
AVNS
$277K ﹤0.01%
7,265
-381
-5% -$14.8K
XHR
2723
Xenia Hotels & Resorts
XHR
$1.79B
$277K ﹤0.01%
16,213
-536
-3% -$9.62K
FIZZ icon
2724
CALL
National Beverage
FIZZ
$3.01B
$276K ﹤0.01%
+33,400
New +$1.01M
FSK icon
2725
FS KKR Capital
FSK
$3.44B
$276K ﹤0.01%
7,031
+719
+11% +$29.4K

Similar funds

Raymond James & Associates's Q1 2017 Portfolio in Review

As of Q1 2017, Raymond James & Associates held 3,508 positions worth $43.1B, up 10% from $39.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Raymond James & Associates's Q1 2017 filing shows 269 new, 1,735 increased, 1,181 reduced and 217 closed positions. Its largest new stake was iShares Global REIT ETF: 2,916,742 shares worth $73.9M. The largest sale was TotalEnergies, an estimated $1.85B.

By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 9.2% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q1 2017 buy was iShares Global REIT ETF: 2,916,742 shares worth $73.9M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2017, an estimated $997M increase.
  • Raymond James & Associates's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $1.85B.
  • Raymond James & Associates fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $23.6M.
  • Raymond James & Associates's ten largest holdings make up 17% of its $43.1B portfolio in Q1 2017.
  • Raymond James & Associates opened 269 new positions and closed 217 in Q1 2017.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $43.1B.

Based on Raymond James & Associates's 13F filing for Q1 2017, filed 15 May 2017.